[A contribution to therapeutic effects of oral and intravenous administration of essential choline phospholipids].
D061605:Administration, Intravenous; D001161:Arteriosclerosis; D002794:Choline; D006801:Humans; D006949:Hyperlipidemias; D054709:Lecithins; D010713:Phosphatidylcholines; D010743:Phospholipids
D054709:Lecithins; D010713:Phosphatidylcholines; D010743:Phospholipids; C011246:essential 303 forte; D002794:Choline
ARTERIOSCLEROSIS; HYPERLIPEMIA; LECITHINS